Considerations for TAVR in Lower-Risk Patients

 
 

Considerations for TAVR in Lower-Risk Patients




AGENDA    

Evolut PRO Data Results Overall

Mattew Williams, MD


Valve Durability/Thrombosis and Hemodynamics: What We Know and Don't Know

Michael J. Reardon, MD
     

Treating Bicuspid Patients

Didier Tchetche, MD
 

Advanced Valve-in-Valve Concepts

Vinayak Bapat, MD
 

Discussion and Audience Q&A

 

 


This program was supported by Medtronic:   Considerations for TAVR in Lower-Risk Patients

2018-07-20T16:03:48Z